Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight

| DelveInsight The gastroesophageal reflux disease market continues to be constrained by a limited number of approved treatment options and persistent unmet needs, particularly among patients who do ...

DelveInsight Business Research, LLP: Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight

The gastroesophageal reflux disease market continues to be constrained by a limited number of approved treatment options and persistent unmet needs, particularly among patients who do not achieve ...
CURE

Key Patient Takeaways From the 2026 ASCO GI Cancers Symposium

Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis on patient-centered decision-making.
New Atlas

Heartburn meds might not cause cancer after all

While heartburn medication can be a lifesaver for those suffering from gastric reflux, several studies over the years have ...

Study reveals weight loss medications may improve outcomes for chronic sinus disease patients

A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...